Site last updated:
July 2010

Cancer Services Forum currently has 713 registered members

Cancer Commissioning—at a global and a local level: London Cancer New Drugs Group Annual Meeting

Conclusions

As in previous years, the LCNDG meeting attracted a packed—and voluble—audience eager to discuss and debate contentions topics in cancer care. Patient access to new, expensive drugs was a core theme, and one that emerged at several points on the agenda. There was evident concern that schemes to improve access could also serve, albeit unintentionally, to increase inequality of healthcare. For many delegates, the meeting provided an insight into the gatekeeper role that PASLU is expected to play in the evaluation of PASs.

Delegates looking around the exhibition stands

The day closed with several delegates calling for a follow-up meeting. Details of which will be announced soon in Cancer Services Forum and on the LCNDG website.

Please use the comments box to let us know your thoughts on the meeting and please let us know of future topics you would like to see covered in Cancer Services Forum by clicking on this link

 

Page 16 of 16

Previous Page


Discussion.

Comment on this Article

Would you like to comment on this article?

You must be a logged in member to join the discussion. Remember, membership is FREE

Signup Free Login

Please Note: We reserve the right to edit or remove any comment that is deemed inappropriate.